Zydus Lifesciences Completes Acquisition of Sterling Biotech API Business
Zydus Lifesciences Ltd 路 Others (Uncategorized) 路 02 Nov 2026, 6:16 pm
Zydus Lifesciences Completes Acquisition of Sterling Biotech API Business Zydus Lifesciences Limited has formally completed the acquisition of the active pharmaceutical ingredient (API) business of Sterling Biotech Limited. The transaction concluded following the fulfillment of all conditions precedent and closing date adjustments outlined in the Business Transfer Agreement originally executed between the parties on 17th Sep'24.
Original exchange filing (PDF)
More announcements from Zydus Lifesciences Ltd
- Press Release 路 14 Nov 2026
- Completion of transaction 路 12 Nov 2026
- Transcript of the post results earnings call held on November 4, 2026. 路 07 Nov 2026
- Press Release 路 07 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India 路 06 Nov 2026
- Investor Conference 路 06 Nov 2026
- Audio recording of the Company's Investor Call 路 05 Nov 2026
- Press Release 路 04 Nov 2026
